Clinical endpoint adjudication

被引：0
|
作者：
Meah, Mohammed N. [1 ]
Denvir, Martin A. [1 ]
Mills, Nicholas L. [1 ]
Norrie, John [1 ]
Newby, David E. [1 ]
机构：
[1] Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland
来源：
LANCET | 2020年 / 395卷 / 10240期
基金：
英国惠康基金;
关键词：
MYOCARDIAL-INFARCTION; EVENT ADJUDICATION; FOLLOW-UP; TRIALS; TICAGRELOR; OUTCOMES; PREVENTION; THERAPY; SURGERY; STROKE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1878 / 1882
页数：5
相关论文
共 50 条
  • [1] Endpoint adjudication in cardiovascular clinical trials
    Khan, Muhammad Shahzeb
    Usman, Muhammad Shariq
    Van Spall, Harriette G. C.
    Greene, Stephen J.
    Baqal, Omar
    Felker, Gary Michael
    Bhatt, Deepak L.
    Januzzi, James L.
    Butler, Javed
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (46) : 4835 - 4846
  • [2] When do we need clinical endpoint adjudication in clinical trials?
    Held, Claes
    [J]. UPSALA JOURNAL OF MEDICAL SCIENCES, 2019, 124 (01) : 42 - 45
  • [3] Machine Learning Can Enable the Automation of Clinical Endpoint Adjudication
    Lea, Halsey
    Nampally, Sreenath
    Hutchison, Emmette R.
    Stedt, Christoffer
    Jaremo, Andreas.
    Persson, Anders
    Weatherall, James
    Khan, Faisal M.
    Andersson, Tomas
    Khader, Shameer
    Dennis, Glynn
    Bhatt, Deepak L.
    Steg, Philippe G.
    [J]. CIRCULATION, 2021, 144
  • [4] Endpoint adjudication in pharmacoepidemological research
    Flynn, Robert W. V.
    Rogers, Amy
    Grieve, Kerr
    Pigazzani, Filippo
    Mackenzie, Isla S.
    MacDonald, Thomas
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 125 - 126
  • [5] EFFECTS OF THE ENDPOINT ADJUDICATION PROCESS ON THE RESULTS OF THE CLINICAL TRIAL: THE ADVANCE STUDY
    Hata, J.
    Arima, H.
    Zoungas, S.
    Anderson, C.
    Woodward, M.
    Ninomiya, T.
    Patel, A.
    Neal, B.
    MacMahon, S.
    Chalmers, J.
    [J]. HYPERTENSION, 2011, 58 (01) : 118 - 118
  • [6] A web-based endpoint adjudication system for interim analyses in clinical trials
    Nolen, Tracy L.
    Dimmick, Bill F.
    Ostrosky-Zeichner, Luis
    Kendrick, Amy S.
    Sable, Carole
    Ngai, Angela
    Wallace, Dennis
    [J]. CLINICAL TRIALS, 2009, 6 (01) : 60 - 66
  • [7] Development of a charter for an endpoint assessment and adjudication committee
    Kradjian, S
    Gutheil, J
    Baratelle, AM
    Einstein, SG
    Kaslow, DC
    [J]. DRUG INFORMATION JOURNAL, 2005, 39 (01): : 53 - 61
  • [8] Development of a Charter for an Endpoint Assessment and Adjudication Committee
    Steve Kradjian
    John Gutheil
    Anna M. Baratelle
    Steven G. Einstein
    David C. Kaslow
    [J]. Drug information journal : DIJ / Drug Information Association, 2005, 39 (1): : 53 - 61
  • [9] Blinded, Independent, Central Image Review in Oncology Trials - Will the Study Endpoint Impact the Adjudication Rate or Will the Adjudication Rate Impact the Study Endpoint?
    Urbank, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S181 - S181
  • [10] Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation
    Vranckx, Pascal
    McFadden, Eugene
    Cutlip, Donald E.
    Mehran, Roxana
    Swart, Michael
    Kint, P. P.
    Zijlstra, Felix
    Silber, Sigmund
    Windecker, Stephan
    Serruys, Patrick W. C. J.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2013, 34 (01) : 53 - 59
12345